W. Jeffrey Edenfield
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Cancer-related Molecular Pathways, Ferroptosis and cancer prognosis, Genetic factors in colorectal cancer, RNA modifications and cancer
Most-Cited Works
- → Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study(2018)109 cited
- → An open-label, multicenter, phase Ib study investigating the effect of apalutamide on ventricular repolarization in men with castration-resistant prostate cancer(2018)26 cited
- → Post-transplant interleukin-2 in patients with low-grade lymphoid neoplasms previously treated with fludarabine is limited by hematologic toxicity(2003)3 cited
- → Prolonged response of widely metastatic HER2-positive colon cancer to trastuzumab therapy(2017)2 cited
- → Phase 1, Open-Label, Randomized, Bioequivalence Study of 2 Bendamustine Hydrochloride Formulations; A Ready-to-Dilute Low-Volume, Rapid Infusion Solution and a Lyophilized Powder Formulation(2015)1 cited
- → Mutational analysis of selected high-grade malignancies in a premenopausal gynecologic cancer population: a potential for targeted therapies?(2018)1 cited
- → Comparative Safety of Two Bendamustine Hydrochloride Formulations; A Ready-to-Dilute Low-Volume, Rapid Infusion Solution, and a Lyophilized Powder: Results from a Phase 1 Study(2015)